Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-α - PubMed (original) (raw)
Comparative Study
. 2013 Jun;52(4):1315-25.
doi: 10.1007/s00394-012-0441-2. Epub 2012 Aug 25.
Affiliations
- PMID: 22923017
- DOI: 10.1007/s00394-012-0441-2
Comparative Study
Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-α
Natalya Filipchuk Vigerust et al. Eur J Nutr. 2013 Jun.
Abstract
Purpose: Biological effects of marine oils, fish oil (FO) and krill oil (KO), are mostly attributed to the high content of n-3 polyunsaturated fatty acids (n-3 PUFAs), predominantly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The study was aimed to investigate the influence of FO and KO on lipid homeostasis and inflammation in an animal model of persistent low-grade exposure to human tumor necrosis factor α (hTNF-α) and to evaluate whether these effects depend on the structural forms of EPA and DHA [triacylglycerols (TAG) vs. phospholipids].
Methods: Male C57BL/6 hTNF-α mice were fed for 6 weeks a high-fat control diet (24.50 % total fats, w/w) or high-fat diets containing either FO or KO at similar doses of n-3 PUFAs (EPA: 5.23 vs. 5.39 wt%, DHA: 2.82 vs. 2.36 wt% of total fatty acids).
Results: We found that KO, containing bioactive n-3 PUFAs in the form of phospholipids, was capable of modulating lipid metabolism by lowering plasma levels of TAG and cholesterol and stimulating the mitochondrial and peroxisomal fatty acid β-oxidation, as well as improving the overall carnitine turnover. Though the administration of FO was not as effective as KO in the lowering of plasma TAG, FO significantly improved the levels of all cholesterol classes in plasma. Except from the increase in the levels of IL-17 in FO-fed mice and a trend to decrease in MCP-1 levels in KO-fed animals, the levels of pro-inflammatory cytokines were not substantially different between treatment groups.
Conclusion: Our findings demonstrate that FO and KO are comparable dietary sources of n-3 PUFAs. However, when quantitatively similar doses of n-3 PUFAs are administered, KO seems to have a greater potential to promote lipid catabolism. The effect of dietary oils on the levels of inflammatory markers in hTNF-α transgenic mice fed a high-fat diet needs further investigations.
Similar articles
- Absorption rate of krill oil and fish oil in blood and brain of rats.
Ahn SH, Lim SJ, Ryu YM, Park HR, Suh HJ, Han SH. Ahn SH, et al. Lipids Health Dis. 2018 Jul 18;17(1):162. doi: 10.1186/s12944-018-0812-7. Lipids Health Dis. 2018. PMID: 30021606 Free PMC article. - Comparison of bioavailability of krill oil versus fish oil and health effect.
Ulven SM, Holven KB. Ulven SM, et al. Vasc Health Risk Manag. 2015 Aug 28;11:511-24. doi: 10.2147/VHRM.S85165. eCollection 2015. Vasc Health Risk Manag. 2015. PMID: 26357480 Free PMC article. Review. - Diets enriched in menhaden fish oil, seal oil, or shark liver oil have distinct effects on the lipid and fatty-acid composition of guinea pig heart.
Murphy MG, Wright V, Ackman RG, Horackova M. Murphy MG, et al. Mol Cell Biochem. 1997 Dec;177(1-2):257-69. doi: 10.1023/a:1006871524271. Mol Cell Biochem. 1997. PMID: 9450671 - Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K, Kralovec J, Bailey-Hall E, Smeberg V, Stark JG, Salem N Jr. Yurko-Mauro K, et al. Lipids Health Dis. 2015 Sep 2;14:99. doi: 10.1186/s12944-015-0109-z. Lipids Health Dis. 2015. PMID: 26328782 Free PMC article. Clinical Trial. - Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid.
Siriwardhana N, Kalupahana NS, Moustaid-Moussa N. Siriwardhana N, et al. Adv Food Nutr Res. 2012;65:211-22. doi: 10.1016/B978-0-12-416003-3.00013-5. Adv Food Nutr Res. 2012. PMID: 22361189 Review.
Cited by
- A Phospholipid-Protein Complex from Krill with Antioxidative and Immunomodulating Properties Reduced Plasma Triacylglycerol and Hepatic Lipogenesis in Rats.
Ramsvik MS, Bjørndal B, Bruheim I, Bohov P, Berge RK. Ramsvik MS, et al. Mar Drugs. 2015 Jul 16;13(7):4375-97. doi: 10.3390/md13074375. Mar Drugs. 2015. PMID: 26193284 Free PMC article. - Preventive and Therapeutic Effects of Krill Oil on Obesity and Obesity-Induced Metabolic Syndromes in High-Fat Diet-Fed Mice.
Hwang SM, Kim YU, Kim JK, Chun YS, Kwon YS, Ku SK, Song CH. Hwang SM, et al. Mar Drugs. 2022 Jul 27;20(8):483. doi: 10.3390/md20080483. Mar Drugs. 2022. PMID: 36005486 Free PMC article. - Determination and structural elucidation of triacylglycerols in krill oil by chromatographic techniques.
Araujo P, Zhu H, Breivik JF, Hjelle JI, Zeng Y. Araujo P, et al. Lipids. 2014 Feb;49(2):163-72. doi: 10.1007/s11745-013-3855-6. Epub 2013 Nov 5. Lipids. 2014. PMID: 24190513 - Krill products: an overview of animal studies.
Burri L, Johnsen L. Burri L, et al. Nutrients. 2015 May 7;7(5):3300-21. doi: 10.3390/nu7053300. Nutrients. 2015. PMID: 25961320 Free PMC article. Review. - Hydroxyeicosapentaenoic acids from the Pacific krill show high ligand activities for PPARs.
Yamada H, Oshiro E, Kikuchi S, Hakozaki M, Takahashi H, Kimura K. Yamada H, et al. J Lipid Res. 2014 May;55(5):895-904. doi: 10.1194/jlr.M047514. Epub 2014 Mar 25. J Lipid Res. 2014. PMID: 24668940 Free PMC article.
References
- Rapid Commun Mass Spectrom. 2004;18(11):1233-8 - PubMed
- Atherosclerosis. 2006 Nov;189(1):19-30 - PubMed
- FEBS Lett. 1977 Dec 15;84(2):229-32 - PubMed
- Am J Kidney Dis. 2003 Apr;41(4 Suppl 4):S4-12 - PubMed
- J Clin Invest. 1995 May;95(5):2409-15 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous